ENTITY
Venus MedTech

Venus MedTech (2500 HK)

109
Analysis
Health CareChina
Venus MedTech (HangZhou) Inc. develops and sells cardiovascular devices. The Company offers products including aorta, compression loading and conveying systems, and pulmonary artery. Venus MedTech (HangZhou) markets its products throughout China.
more
Refresh
16 Aug 2020 17:17

HSCI Index Rebalance - Stock Connect Flows Coming Up

The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes post market close on 14 August....

Logo
472 Views
Share
22 Jul 2020 05:39

HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities

Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...

Logo
745 Views
Share
28 Jun 2020 13:45

Kangji Medical IPO: Trading Debut

Kangji Medical (9997 HK) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...

Logo
397 Views
Share
16 Jun 2020 19:19

Hygeia Healthcare IPO (Part I): A Better Healthcare

Hygeia Healthcare is an oncology healthcare service provider in China who operates hospitals as well as provides third-party radiotherapy services...

Share
16 Jun 2020 00:25

Kangji Medical IPO: Valuation Insights

Kangji Medical (1498779D CH) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...

Logo
353 Views
Share
x